Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy.

Choe J, Shields A, Ferreira A, Gold S, Gotschall JW, Kamal K, Rios A, Wang RH, Baumrin E, Dommasch ED, Yeung H, Lipoff JB, Barbieri JS

Open source

DOI
10.1001/jamadermatol.2024.1420
Published
2024 Jul 1
Container
JAMA dermatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2024.1420,
  title = {Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy.},
  author = {Choe J and Shields A and Ferreira A and Gold S and Gotschall JW and Kamal K and Rios A and Wang RH and Baumrin E and Dommasch ED and Yeung H and Lipoff JB and Barbieri JS},
  year = {2024},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2024.1420},
  url = {https://doi.org/10.1001/jamadermatol.2024.1420}
}

RIS

TY  - JOUR
TI  - Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy.
AU  - Choe J
AU  - Shields A
AU  - Ferreira A
AU  - Gold S
AU  - Gotschall JW
AU  - Kamal K
AU  - Rios A
AU  - Wang RH
AU  - Baumrin E
AU  - Dommasch ED
AU  - Yeung H
AU  - Lipoff JB
AU  - Barbieri JS
PY  - 2024
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2024.1420
UR  - https://doi.org/10.1001/jamadermatol.2024.1420
ER  - 

APA

J, C., A, S., A, F., S, G., JW, G., K, K., A, R., RH, W., E, B., ED, D., H, Y., JB, L., & JS, B. (2024). Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2024.1420

Source records